Friday 20 April 2018
Contact US    |    Archive
WSJ
4 months ago

Teva Pharma to Cut 14,000 Jobs as Generic-Drug Business Suffers

Teva Pharmaceutical is cutting more than 25% of its workforce and suspending its dividend as it works to cut costs and pay down debt.

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

Teva

 | 

Pharma

 | 

Cut

 | 

000

 | 

Jobs

 | 

Generic

 | 

Drug

 | 

Business

 | 

Suffers

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
USA